Iovance

IOVA

IOVA Iovance NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    IOVA Chart
    See on advanced chart >

    About

    Iovance Biotherapeutics, Inc. is an emerging biotechnology company focused on developing and commercializing adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of metastatic melanoma and other solid cancers....
    • Highlight
      A late-stage biotech company that develops novel T cell-based cancer immunotherapies
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/26/2015
    • Established Date
      09/17/2007
    • Full-time Employees
      503
    • Address
      825 Industrial Road Suite 400 San Carlos California 94070
    • Tel
      1-650-2607120
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-02-29 03:48:45